| Literature DB >> 28074801 |
Ashok K Kumar1, Aveek Jayant1, V K Arya1, Rohan Magoon1, Ridhima Sharma1.
Abstract
BACKGROUND: Advances in cardiac surgery has shifted paradigm of management to perioperative psychological illnesses. Delirium is a state of altered consciousness with easy distraction of thoughts. The pathophysiology of this complication is not clear, but identification of risk factors is important for positive postoperative outcomes. The goal of the present study was to prospectively identify the incidence, motoric subtypes, and risk factors associated with development of delirium in cardiac surgical patients admitted to postoperative cardiac intensive care, using a validated delirium monitoring instrument.Entities:
Mesh:
Year: 2017 PMID: 28074801 PMCID: PMC5290701 DOI: 10.4103/0971-9784.197841
Source DB: PubMed Journal: Ann Card Anaesth ISSN: 0971-9784
Demographic characteristics
| Group | |||
|---|---|---|---|
| Control, | Case, | ||
| Age (years) | |||
| ≤60 | 73 (73.7) | 8 (38.1) | 0.002 |
| >60 | 26 (26.3) | 13 (61.9) | |
| Gender | |||
| Male | 65 (65.7) | 12 (57.1) | 0.460 |
| Female | 34 (34.3) | 9 (42.9) | |
| Education | |||
| High school and below | 58 (58.6) | 11 (52.4) | 0.601 |
| Above high school | 41 (41.4) | 10 (47.6) | |
| Marital status | |||
| Unmarried | 14 (14.1) | 0 | 0.144** |
| Married | 85 (85.9) | 21 (100.0) | |
**Yate’s corrected Chi-square test
Preoperative factors
| Group | |||
|---|---|---|---|
| Controls ( | Cases ( | ||
| Diagnosis | |||
| Valvular heart disease | 44 (44.4) | 9 (42.9) | 0.894 |
| Coronary artery disease | 36 (36.4) | 11 (52.4) | 0.172 |
| Acyanotic congenital heart disease | 10 (10.1) | 1 (4.8) | 0.723** |
| Congenital cyanotic heart disease | 2 (2.0) | 0 | 0.778** |
| Vascular surgery | 7 (7.1) | 0 | 0.457** |
| Drug abuse | 2 (2.0) | 1 (4.8) | 1.000** |
| Alcoholic | 12 (12.1) | 4 (19.0) | 0.621** |
| HTN | 27 (27.3) | 15 (71.4) | <0.0001 |
| Diabetes | 15 (15.2) | 8 (38.1) | 0.034** |
| Thyroid disease | 4 (4) | 0 | 0.789** |
| History of cardiac surgery | 9 (9.1) | 2 (9.5) | 1.000** |
| History of stroke | 5 (5.1) | 2 (9.5) | 0.778** |
| Vascular disease | 4 (4.0) | 1 (4.8) | 1.000** |
| Depression | 1 (1.0) | 0 | 1.000** |
| Renal dysfunction | 3 (3.0) | 4 (19.0) | 0.020** |
| LVEF<30% | 8 (8.1) | 0 | 0.386** |
| Atrial fibrillation | 17 (17.2) | 1 (4.8) | 0.267** |
| Emergency surgery | 7 (7.1) | 1 (4.8) | 1.000** |
| Cardiogenic shock | 2 (2) | 0 | 1.000** |
| Severe PAH% | 8 (8.1) | 1 (4.8) | 0.945** |
| NYHA 3 or 4 | 36 (36.4) | 14 (66.7) | 0.011 |
| Premedication | 88 (88.9) | 18 (85.7) | 0.970** |
| Carotid artery disease | 5 (5.1) | 7 (33.3) | <0.0001 |
**Yate’s corrected Chi-square test. LVEF: Left ventricular ejection fraction, PAH: Pulmonary artery hypertension, NYHA: New York Heart Association, HTN: Hypertension
Intraoperative factors
| Group | |||
|---|---|---|---|
| Controls ( | Cases ( | ||
| Induction agent | |||
| Propofol | 98 (99.0) | 18 (85.7) | 0.015** |
| Midazolam | 1 (1.0) | 1 (4.8) | 0.778** |
| Thiopentone | 0 | 1 (4.8) | 0.390** |
| Ketamine | 0 | 1 (4.8) | 0.390** |
| Blood transfusion | 42 (42.4) | 11 (52.4) | 0.404 |
| Temperature (°C) | |||
| <28 | 5 (5.1) | 1 (4.8) | 1.000** |
| >36 | 46 (46.5) | 9 (42.9) | 0.763 |
| Phenylephrine use (min) | |||
| >5 | 21 (21.2) | 7 (33.3) | 0.363** |
| CPB time (min) | |||
| ≤60 | 6 (6.1) | 1 (4.8) | 0.778** |
| 61-120 | 25 (25.3) | 4 (19.0) | 0.546 |
| >120 | 68 (68.7) | 16 (76.2) | 0.495 |
| Aortic clamp time (min) | |||
| ≤60 | 13 (13.1) | 2 (9.5) | 0.927** |
| 61-120 | 55 (55.6) | 13 (61.9) | 0.593 |
| >120 | 31 (31.3) | 6 (28.6) | 0.804 |
**Yate’s corrected Chi-square test. CPB: Cardiopulmonary bypass
Postoperative factors
| Group | |||
|---|---|---|---|
| Controls ( | Cases ( | ||
| Reoperation | 3 (3.0) | 0 | 0.969** |
| Postoperative atrial fibrillation | 24 (24.2) | 3 (14.3) | 0.481** |
| Postoperative blood transfusion | 51 (51.5) | 16 (76.2) | 0.039 |
| FFP/platelet transfusion | 37 (37.4) | 10 (47.6) | 0.382 |
| Postoperative cardiogenic shock | 4 (4.0) | 2 (9.5) | 0.620** |
| IABP use | 2 (2.0) | 3 (14.3) | 0.051** |
| Postoperative infection | 2 (2.0) | 1 (4.8) | 1.000** |
| Hematocrit <30 | 44 (44.4) | 15 (71.4) | 0.025 |
| Creatinine >2 mg/dL | 5 (5.1) | 6 (28.6) | 0.003** |
| Bilirubin >2 mg/dL | 6 (6.1) | 2 (9.5) | 0.923** |
| Atropine use | 1 (1.0) | 1 (4.8) | 0.778** |
| Postoperative pain | 17 (17.2) | 9 (75) | 0.0212** |
| Sodium >140 mEq | 30 (30.3) | 10 (47.6) | 0.126 |
| PaO2 <70 mmHg | 7 (7.1) | 0 | 0.457** |
| NIV used | 14 (14.1) | 9 (42.9) | 0.006** |
| Prolonged hypotension | 33 (33.3) | 8 (38.1) | 0.676 |
| Sleep deprivation | 10 (10.1) | 3 (14.3) | 0.862** |
| Postoperative drain (ml) | |||
| ≤500 | 80 (80.8) | 16 (76.2) | 0.857** |
| 501-1000 | 14 (14.1) | 4 (19.0) | 0.813** |
| >1000 | 5 (5.1) | 1 (4.8) | 0.619** |
| Mechanical ventilation time | |||
| <12 h | 19 (19.2) | 3 (14.3) | 0.828** |
| 12-24 h | 68 (68.7) | 12 (57.1) | 0.310 |
| 25-48 h | 7 (7.1) | 2 (9.5) | 0.945** |
| 49-72 h | 2 (2.0) | 1 (4.8) | 0.969** |
| >3 days | 3 (3.0) | 3 (14.3) | 0.110** |
| ICU stay (days) | |||
| 1-5 | 71 (71.7) | 8 (38.1) | 0.003 |
| 6-10 | 26 (26.3) | 8 (38.1) | 0.275 |
| >10 | 2 (2.0) | 5 (23.8) | 0.0008** |
**Yate’s corrected Chi-square test. NIV: Noninvasive ventilation, ICU: Intensive Care Unit, IABP: Intra-aortic balloon pump, FFP: Fresh frozen plasma
Logistic regression analysis with bootstrapping: Relative risk for variables associated with delirium
| Risk factors | RR with CI | |
|---|---|---|
| History of HTN | 6.7857 (2.4067-19.1327) | 0.0003 |
| Carotid artery disease | 4.5000 (2.2713-8.9157) | <0.0001 |
| ICU stay >10 days | 5.0446 (2.6272-9.6864) | <0.0001 |
| NIV use | 3.1630 (1.5166-6.5970) | 0.0021 |
| Postoperative pain | 2.4958 (1.2944-4.8123) | 0.0063 |
HTN: Hypertension, ICU: Intensive Care Unit, NIV: Noninvasive ventilation, CI: Confidence interval, RR: Relative risk